Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
VivoPower Shares Surge On $120 Million Takeover Proposal From UAE-Based Energi Holdings
March 26, 2025
From Benzinga
From Benzinga
Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year
March 26, 2025
From Benzinga
From Benzinga
What's Going On With General Dynamics Stock Today?
March 26, 2025
From Benzinga
From Benzinga
BRP Stock Climbs After Q4 Earnings Top Estimates, Outlook Held Back Amid Trade Uncertainty
March 26, 2025
From Benzinga
SailPoint Q4 Earnings: 29% ARR Growth, Strong SaaS Momentum, Projects Up To $1.08 Billion ARR In 2026
March 26, 2025
From Benzinga
In Geopolitical Chess, China's Latest Energy Norms Block Nvidia's Chip Strategy Amid US Sanctions
March 26, 2025
From Benzinga
From Benzinga
Pet Goods Retailer Chewy Reports Better-Than-Expected Q4 Earnings, Topline Growth And Profitability Exceed Guidance
March 26, 2025
From Benzinga
What's Going On With Electronics Maker Kopin's Stock Today?
March 26, 2025
From Benzinga
JinkoSolar Cautious On 2025 Capacity Expansion After Q4 Loss And Market Headwinds: Details
March 26, 2025
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
March 26, 2025
From Benzinga
Dollar Tree To Offload Family Dollar Business For $1 Billion, Anticipates 3% To 5% Standalone Same-Store Sales Growth
March 26, 2025
From Benzinga
Asia Markets Mixed, Europe Down As Tariff Concerns Persist - Global Markets Today While US Slept
March 26, 2025
From Benzinga
Bridger Aerospace Expands With Exclusive North American Deal For New Firefighting Aircraft
March 26, 2025
From Benzinga
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
March 26, 2025
From Benzinga
From Benzinga
Kroger Files Counterclaims Against Albertsons, Seeks Damages
March 26, 2025
From Benzinga
From Benzinga
From Benzinga
HealthEquity Earns Stock Upgrade Despite Fraud Concerns
March 25, 2025
From Benzinga
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside
March 25, 2025
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.